Abstract

Summary

This review covers the classification of retinal ganglion cell subtypes by morphological, functional, genetic, and immunohistochemical criteria, alongside diagnostic tools and biomarkers for RGC cell death—critical for understanding conditions like glaucoma that impair light signal transmission. For lighting and healthcare professionals, the finding that different RGC subtypes (including ipRGCs involved in circadian entrainment) show differential vulnerability to injury has implications for monitoring non-visual light pathway integrity in aging and neurodegenerative disease populations.
Abstract

Key Findings

  • RGC degeneration is a measurable endpoint across multiple ocular pathologies including glaucoma, and different RGC subtypes exhibit differential susceptibility to injury.
  • Retinal analysis can serve as a non-invasive biomarker of CNS health, with RGC changes observed in Alzheimer's and Parkinson's diseases.
  • No consensus RGC subtype classification currently exists; subtypes are distinguished across morphological, functional, genetic, and immunohistochemical dimensions.
  • Review identifies both programmed (apoptotic) and unprogrammed cell death pathways in RGCs, relevant to developing neuroprotective therapies.
Categories

Categories

Eye Health & Vision: Reviews retinal ganglion cell (RGC) degeneration, subtypes, and biomarkers relevant to glaucoma and other ocular pathologies.
The Science of Light: RGCs include intrinsically photosensitive cells (ipRGCs) that are central to non-visual light processing; understanding RGC subtypes informs photoreceptor biology.
Dementia & Elder Care: Highlights RGC analysis as a biomarker window into CNS health in neurodegenerative diseases such as Alzheimer's and Parkinson's.
Authors

Author(s)

C Corral-Domenge, P de la Villa, A Mansilla
Publication Date

Publication Year

2022
Citations

Number of Citations

12
View more publications